Humasis
↗Anyang-si, South Korea
Humasis Co., Ltd. is a prominent South Korean medical device company specializing in the development and manufacturing of in-vitro diagnostic (IVD) products. Founded in 2000, the company has established itself as a leader in Point-of-Care Testing (POCT), offering a wide range of rapid test kits for infectious diseases, cardiovascular markers, cancer markers, and hormone levels. Humasis gained significant global recognition during the COVID-19 pandemic for its rapid antigen tests, which received FDA Emergency Use Authorization (EUA) and CE marking.
In recent years, following its acquisition by GP Club in early 2023, Humasis has begun diversifying its business portfolio. While maintaining its core diagnostics business, the company has expanded into the mineral resources sector, specifically targeting lithium mining and secondary battery materials in regions like Zimbabwe. This strategic pivot aims to secure new growth engines as the global demand for pandemic-related diagnostics stabilizes.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:In-vitro Diagnostics (IVD)
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:2000
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:GP Club, Institutional Investors
STOCK
Exchange:KOSDAQ
Ticker:205470
Market Cap:$165M
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Lateral Flow Immunoassay, Molecular Diagnostics, POCT Analyzers
Active Trials:2
Trial Phases:-
FDA Approvals:1
EMA Approvals:12
CORPORATE STRUCTURE
Parent Company:GP Club
Acquired By:GP Club (Majority Stakeholder) (2023-01-01)
Subsidiaries:Humasis Vina (Vietnam), Humasis Zimbabwe (Mining), Humasis USA
Key Partnerships:Celltrion (Co-development and supply of COVID-19 tests), Various global NGOs for malaria and dengue screening
COMPETITION
Position:Challenger
Competitors:SD Biosensor, Seegene, Abbott Laboratories, QuidelOrtho, Roche Diagnostics
LEADERSHIP
Key Executives:
Nam-Gung Gyeon - Chairman & CEO
Cha Geun-sik - Founder / Former CEO
Scientific Founders:Cha Geun-sik
Board Members:Nam-Gung Gyeon, Kim Won-hee
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Humasis. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.